Institutional investors hold a majority ownership of AMGN through the 82.02% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $6.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 854.6 Thousand shares of Amgen Inc
STRATEGIC ADVISERS, INC. Bought 253.6 Thousand shares of Amgen Inc
SWEDBANK ROBUR FONDER AB Bought 229.2 Thousand shares of Amgen Inc